Polarean Imaging Ltd (POLX) ORD GBP0.00037
- Add to watchlist
- Create an alert
- This stock can be held in a
4.30p
4.40p
32.00p
£9.30 million
4.30p
4.20p
3.90p
n/a
0.20p (4.44%) Previous:
0.20p
2,223,270
n/a
10,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2022 | 31/12/2021 |
---|---|---|
Revenue ($m) | 1.03 | 1.19 |
Profit before tax ($m) | (13.91) | (14.02) |
Adjusted EPS (¢): | (6.60) | (7.10) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Polarean gets first de novo order for Xenoview polariser
7 December 2023 16:01
-
Polarean Imaging enters strategic partnership with VIDA Diagnostics
8 September 2023 14:12
-
Polarean's Xenoview gets US reimbursement code
29 August 2023 14:22
-
Exercise of Warrants, Issue of Equity and TVR
14 March 2024 07:00
-
Holding(s) in Company
12 March 2024 15:59
-
2024 Polarean Strategy Update
29 February 2024 07:00
Recent trade data is unavailable. We will be replacing it, however in the meantime the information is available on the London Stock Exchange website.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.